In a different investigation, Wildeman et al. developed a predictive model to predict locoregional control in laryngeal cancer patients receiving radiation therapy by combining clinical variables (T-stage, N-stage, and tumor site) with genetic markers (p53 and EGFR expression) [133]. This evidence concerns the gene TP53 and neoplasm.